Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard […]
August 2014 Life Science Industry Research Reports
PharmaPoint: Asthma – Current and Future Players
GlobalData has released its pharma report, “PharmaPoint: Asthma Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Asthma Market. The report identifies and analyses the key […]
Dupilumab (Asthma) – Forecast and Market Analysis to 2023
GlobalData has released its new PharmaPoint Drug Evaluation report, “Dupilumab (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]
Advair (Asthma) – Forecast and Market Analysis to 2023
GlobalData has released its new PharmaPoint Drug Evaluation report, “Advair (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]
Dulera (Asthma) – Forecast and Market Analysis to 2023
GlobalData has released its new PharmaPoint Drug Evaluation report, “Dulera (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]
Pulmicort (Asthma) – Forecast and Market Analysis to 2023
GlobalData has released its new PharmaPoint Drug Evaluation report, “Pulmicort (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]
Spiriva (Asthma) – Forecast and Market Analysis to 2023
GlobalData has released its new PharmaPoint Drug Evaluation report, “Spiriva (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]
Cinquil (Reslizumab) (Asthma) – Forecast and Market Analysis to 2023
GlobalData has released its new PharmaPoint Drug Evaluation report, “Cinquil (Reslizumab) (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, […]
Fluticasone Furoate (Asthma) – Forecast and Market Analysis to 2023
GlobalData has released its new PharmaPoint Drug Evaluation report, “Fluticasone Furoate (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, […]
Flutiform (Asthma) – Forecast and Market Analysis to 2023
GlobalData has released its new PharmaPoint Drug Evaluation report, “Flutiform (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]